A round table discussion held in January 2016 – chaired by Professor John Marshall with a panel of experts representing research, ophthalmology, academia and retail optometry – set out to determine the extent to which blue light is a hazard to the human eye and to establish whether it is implicated in disease such as age-related macular degeneration (AMD).
Discussions included the availability of existing research and the likelihood of future studies being conducted, which will help support the increasing body of evidence that blue light is a concern for eye health. They concluded by suggesting how this potential risk should be discussed in the practice environment.
Article from the magazine "Point de vue"
Macular degeneration (AMD) and cataracts play a major role in the United States health care system and global effort directed to the prevention of these conditions now is part of optometry initiatives. To benefit society both from a financial and a productivity perspective, optometrists focus on four areas in clinical practice: protective lenses, nutraceuticals, genetic testing and periodic examinations.
Light-induced ocular damage has been investigated for decades in laboratory extensive work and several epidemiological studies. More recently, harmful effects of blue-violet light have been spotlighted by growing body of scientific research. Despite the eye’s natural defense mechanisms, it has been evidenced that cumulative exposure to blue-violet light can contribute to long-term irreversible changes in the retina. When the most critical exposure occurs in outdoor conditions, Transitions® lenses can effectively filter harmful blue-violet light and consequently provide optimal photo-protection for the patient eyes.
Article from the magazine "Point de vue"